Free Trial
→ What Elon Musk's Cybercab Reveal Could Mean for Investors (From Brownstone Research) (Ad)tc pixel
OTCMKTS:EKTAY

Elekta Earnings Date & Estimates

Elekta logo
$5.92 +0.01 (+0.17%)
As of 10/30/2026 09:51 AM Eastern

Elekta is estimated to report earnings on Wednesday, November 25, 2026, before market opens.

Research:ProfileEarnings HistoryForecast

Upcoming Earnings Announcement

Announcement Date
Time
Before Market Opens
Google Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab)

What Analysts Expect from Elekta

Elekta is expected to post earnings of $0.09 per share on revenue of $423.96 million. In the same quarter a year earlier Elekta reported $0.07 per share on revenue of $427.85 million.

Consensus Estimates

Consensus EPS
$0.09
Expected Revenue
$423.96 million
Prior-Year EPS
$0.07
Prior-Year Revenue
$427.85 million
Expected EPS Growth
+28.6%
Expected Revenue Growth
-0.9%

Recent Track Record

Last Reported
Q1 2027
Last Quarter EPS
$0.07
Last Quarter Revenue
$372.30 million

Prepare for the Earnings Call

Elekta Earnings FAQ

Elekta (OTCMKTS:EKTAY) is estimated to report earnings on Wednesday, November 25, 2026, before market opens. This date is estimated from past reporting schedules and may change once the company confirms it.

Analysts expect Elekta to post earnings of $0.09 per share for the quarter.

The consensus revenue estimate for Elekta is $423.96 million for the quarter.

Elekta Earnings Headlines

Critical Review: Elekta (OTCMKTS:EKTAY) and SiBone (NASDAQ:SIBN)
October 30 at 4:16 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31168312
Elekta names investor-led Nomination Committee ahead of 2027 AGM
October 30 at 3:11 AM  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/elekta-names-investor-led-nomination-committee-ahead-of-2027-agm?utm_source=marketbeat.com&utm_medium=referral
Federal Reserve Reveals Disturbing New Plan To Control Your Money
Docket No. OP-1670 is drawing attention for what it reveals about the Federal Reserve's next move. Buried on page 84 is a plan that could expand oversight of checking accounts, purchases, and money transfers across the country. Martin D. Weiss, PhD, founder of Weiss Ratings, breaks down what this document means and why it could roll out as soon as this summer.tc pixel
 |  Weiss Ratings (Ad)
Elekta data support expanded use of Gamma Knife for multiple brain metastases
September 29, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/elekta-data-support-expanded-use-of-gamma-knife-for-multiple-brain-metastases?utm_source=marketbeat.com&utm_medium=referral
Elekta’s Unity Data Boost Pancreatic Cancer Outcomes as Unity Pro Rolls Out
September 28, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/elektas-unity-data-boost-pancreatic-cancer-outcomes-as-unity-pro-rolls-out?utm_source=marketbeat.com&utm_medium=referral
Elekta Broadens Adaptive Radiotherapy Portfolio Across Modalities
September 27, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/elekta-broadens-adaptive-radiotherapy-portfolio-across-modalities?utm_source=marketbeat.com&utm_medium=referral
See More Elekta Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Elekta? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Elekta and other key companies, straight to your email.

About Elekta

Elekta (OTCMKTS:EKTAY) is a Sweden-based medical technology company that develops and supplies systems and software for radiation therapy, radiosurgery and related cancer-care applications. Its solutions are designed to help hospitals and clinics treat tumors while supporting more precise, personalized and less invasive care.

The company’s portfolio includes linear accelerators, stereotactic radiosurgery systems, magnetic resonance-guided radiation therapy technology and brachytherapy products. Elekta also provides oncology information systems and workflow software, including platforms used for treatment planning, patient management and clinical data coordination.

Founded in 1972 by neurosurgeon and inventor Lars Leksell, Elekta initially focused on radiosurgery and later expanded into broader radiation oncology. The company serves healthcare providers internationally, with operations and customers across Europe, the Americas, Asia and other global markets. Elekta is headquartered in Stockholm, Sweden, and is led by President and Chief Executive Officer Gustaf Salford.

View Elekta Profile
Earnings Tools